Health Insurance Innovations CEO Sells $60,678 in Stock (HIIQ)
Health Insurance Innovations (NASDAQ:HIIQ) CEO Michael W. Kosloske sold 5,943 shares of the company’s stock on the open market in a transaction dated Thursday, June 5th. The shares were sold at an average price of $10.21, for a total transaction of $60,678.03. Following the transaction, the chief executive officer now directly owns 30,772 shares of the company’s stock, valued at approximately $314,182. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Health Insurance Innovations (NASDAQ:HIIQ) traded up 1.53% during mid-day trading on Thursday, hitting $9.95. The stock had a trading volume of 37,961 shares. Health Insurance Innovations has a one year low of $8.39 and a one year high of $14.08. The stock has a 50-day moving average of $10.03 and a 200-day moving average of $10.77. The company has a market cap of $51.4 million and a price-to-earnings ratio of 184.91.
Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.08. On average, analysts predict that Health Insurance Innovations will post $0.39 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Health Insurance Innovations from an “underperform” rating to a “neutral” rating in a research note on Tuesday, May 20th. They now have a $10.80 price target on the stock. Separately, analysts at Raymond James reiterated a “strong-buy” rating on shares of Health Insurance Innovations in a research note on Monday, April 14th. They now have a $15.00 price target on the stock.
Health Insurance Innovations, Inc is a developer and administrator of Web-based individual health insurance plans and ancillary products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.